THE LEADER OF NONINVASIVE FLUID STATUS & BODY MASS COMPOSITION ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) tech...
THE LEADER OF NONINVASIVE FLUID STATUS & BODY MASS COMPOSITION ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed's primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.
Public Symbol
IPD
Founded Year
1999
Organization Website
impedimed.com
Organization Languages
English
Organization Revenue
7000
Current Technologies
cloudflare dns
outlook
mailchimp spf
apache
mobile friendly
google translate api
wordpress com
wordpress org
google font api
google analytics
amadesa
facebook web custom audiences
google translate widget
facebook widget
youtube
facebook login
woo commerce
cloudflare dns
facebook login
Job Functions
Sales
Engineering
Support
Product Management
Finance
Marketing
Operations
Business Development
Information Technology
Human Resources
Media And Commmunication
Consulting
Accounting
surviving cancer without compromising lifestyle medical devices